BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Cantor Fitzgerald
AstraZeneca
Daiichi Sankyo
US Army
Deloitte
Boehringer Ingelheim
QuintilesIMS
Dow
Teva

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021780

« Back to Dashboard

NDA 021780 describes NITROMIST, which is a drug marketed by Mist Pharms Llc and is included in one NDA. It is available from three suppliers. Additional details are available on the NITROMIST profile page.

The generic ingredient in NITROMIST is nitroglycerin. There are thirty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 021780
Tradename:NITROMIST
Applicant:Mist Pharms Llc
Ingredient:nitroglycerin
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 021780
Ingredient-typeNitrates
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for 021780
Suppliers and Packaging for NDA: 021780
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NITROMIST nitroglycerin AEROSOL, METERED;SUBLINGUAL 021780 NDA Akrimax Pharmaceuticals, LLC 24090-410 24090-410-99 1 BOTTLE in 1 CARTON (24090-410-99) > 230 AEROSOL, METERED in 1 BOTTLE
NITROMIST nitroglycerin AEROSOL, METERED;SUBLINGUAL 021780 NDA Akrimax Pharmaceuticals, LLC 24090-410 24090-410-08 1 BOTTLE in 1 CARTON (24090-410-08) > 230 AEROSOL, METERED in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;SUBLINGUALStrength0.4MG/SPRAY
Approval Date:Nov 2, 2006TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Cipla
Medtronic
Baxter
Queensland Health
UBS
Argus Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot